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Abstract Prostate cancer is the second most common
cancer in American men and new surgical techniques have
led to less invasive options for prostate surgery. Innova-
tions in robotic technology have enabled robotic systems to
become a more common sight in operating theatres
throughout the United States. Approximately 1,500 con-
secutive patients scheduled for elective robotic prostatec-
tomy (RP) were reviewed. Patient demographics were
recorded and significant intraoperative and postoperative
events were reviewed. At our institution the mean age for
patients undergoing RP is 60.3 (41–79) years; the mean
body mass index is 27.3 kg m–2. The mean operative time,
defined as the time from the start of insufflation to closure
is 177.5 (81–365) min and mean blood loss is 109 (50–
750) mL. There was a 1.3% incidence of postoperative
anemia (hemoglobin <10 g dL) where patients required
blood transfusions (15/1,500). Three patients were diag-
nosed with postoperative pulmonary emboli and were
treated with IV heparin with no additional sequelae. The
most common anesthesia-related complication was corneal
abrasions, which were seen in 3% of cases. One patient
required postoperative mechanical ventilation because of
laryngeal edema secondary to multiple intubation attempts
from an unexpectedly difficult airway. Anesthetic and
perioperative complications are rare for patients undergo-
ing robotic-assisted laparoscopic prostatectomy at our
institution. Our institution has performed more robotic
prostatectomies than any other institution in the world and
we review our experience delivering anesthesia for the first
1,500 patients undergoing this operation.
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Introduction
With the exception of non-melanoma skin cancer, cancer
of the prostate is the most common cancer in American
men. In 2006, it was estimated there were over 234,460
new cases of prostate cancer diagnosed, with over 27,350
deaths attributable to the disease, in the United States [1].
Since the widespread use of the prostate specific antigen
(PSA) test, prostate cancer has been detected earlier,
usually presenting as elevated serum PSA [2].
Options for the patient with early prostate cancer include
surgery, radiation therapy, and watchful waiting [3]. Rad-
ical prostatectomy is the only treatment shown in ran-
domized clinical trials to improve disease-specific survival
and overall survival, however [4]. For patients who un-
dergo traditional radical prostatectomy, complications in-
clude urinary incontinence and impotence, both because of
damage to the urinary sphincter and penile nerves [3].
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These adverse effects can cause significant changes in
quality of life and discourage patients from seeking sur-
gical intervention.
The advent of minimally invasive surgical treatment of
prostate cancer has increased patient acceptance of this
option, despite the absence of randomized clinical trials
showing significant advantages of this approach [5].
Technological improvements have recently enabled robotic
manipulation techniques to become a more common sight
in operating theatres throughout the United States. Robotic
prostatectomy (RP) utilizing the da Vinci surgical system
(Intuitive Surgical, Sunnyvale, CA, USA) has been per-
formed at our institution since October 2000. The da Vinci
system is an elegant and sophisticated ‘‘master–slave’’
robot incorporating advanced three-dimensional optics
with three robotic arms. One of the arms controls an
endoscope and the other two arms are ‘‘slaved’’ to two
control handles housed in mobile control console [5]. The
Vattikuti Institute prostatectomy or VIP is a method of RP
developed by surgeons at Henry Ford Hospital that involves
extensive nerve sparing techniques utilizing both trans-
peritoneal and extraperitoneal dissection. Since the first
case in 2001, more than 40,000 operations have been
performed worldwide. Our institution has performed more
RPs than any other institution in the world and in 2006 more
than 30,000 patients underwent the VIP RP worldwide.
With Institutional Review Board Approval and waived
consent, we review our experience delivering anesthesia
for the first 1,500 patients undergoing this operation.
Preoperative evaluation
Patients undergo a complete history and physical with
particular attention to cardiovascular, pulmonary, and
endocrine co-morbidities that affect men who are at highest
risk of prostate cancer (40–80 years old). At our institution
the mean age for patients undergoing RP is 60.3 (41–79)
years. Routine preoperative evaluation includes electro-
cardiography, chest X-ray, hematocrit, and electrolyte
screening which is used to aid identification of underlying
myocardial ischemia, chronic obstructive pulmonary dis-
ease, anemia, and hyperglycemia. This patient population
has an increased likelihood of tobacco abuse, coronary
artery disease, and renal abnormalities secondary to pros-
tatic obstruction. Low functional status or any signs sug-
gestive of cardiac failure may lead to further cardiovascular
testing including transthoracic echocardiogram for evalu-
ation of systolic or diastolic dysfunction, segmental wall
motion abnormalities, or valvular abnormality. Underlying
pulmonary dysfunction, particularly chronic obstructive
pulmonary disorder, places the patient at higher risk for
this laparoscopic procedure, that often results in high peak
airway pressures to overcome the large intra-abdominal
pressure (IAP) increases seen with pneumoperitoneum
(PnP) and steep Trendelenburg position [6]. At our insti-
tution any patient who is a suitable candidate for conven-
tional retropubic (open) radical prostatectomy is a
candidate for RP.
Obese patients (body mass index >30 kg m–2) require
special consideration, because these patients may have an
unexpectedly difficult airway, and are at higher risk of
coronary artery disease, pulmonary dysfunction, and dia-
betes [7–9]. Mean body mass index in these 1,500 patients
was 27.3 kg m–2. Because of technical difficulties associ-
ated with increased body weight, in our earlier experience
we observed an increase in surgical time. With our current
experience, however, operative times are not significantly
different, nor does there seem to be any increased risk of
either blood transfusion or prolonged hospital stay.
Preoperative medications
All patients are instructed to be on a clear liquid diet
starting one day before surgery and to stop taking anything
orally after midnight preceding the surgery [6]. Although
patients may take home medications, diabetic patients are
typically instructed to withhold morning insulin doses and
oral hypoglycemics secondary to their nil per oral (NPO)
status. For diabetic patients, strict glycemic control (80–
110 mg dL–1) is maintained in the perioperative period.
Aspirin and antiplatelet medication are held for two weeks
before the procedure, because even the slightest bleeding
may obscure the surgical field [6]. A full bowel preparation
is not necessary, but patients are required to use a laxative
on the day before surgery [6].
Patients with gastroesophageal reflux are pretreated with
an H2-antagonist (ranitodine/famotidine) and/or a non-
particulate antacid (sodium citrate), preoperatively, to re-
duce the risk of complications associated with aspiration
pneumonitis. Preoperative antibiotic prophylaxis is given
within 1 h of incision. We use 1–2 g cefazolin or 1 g
vancomycin for penicillin-allergic patients. Preoperative
administration of 5,000 U subcutaneous heparin and
sequential compression devices (SCDs) are used for deep
venous thrombosis prophylaxis.
Monitoring
Because of relatively short operative times (insertion of
pneumoinsufflation needle to closure of incision) of 177.5
(81–365) min and minimal blood loss (mean blood loss is
109 (50–750) mL at our institution), invasive monitoring
for VIP patients is rarely indicated. We have found that one
freely flowing peripheral IV and plethysmography offer
necessary access and hemodynamic information. If a
perioperative cardiovascular emergency arises, trans-
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esophageal echocardiography is the most effective means
of assessing cardiac function. With regard to these rec-
ommendations, it may be prudent at institutions becoming
familiar with RP, and where prolonged operative times are
expected, to place invasive monitors preoperatively in
higher risk patients, because access to the patient is limited
as soon as the robot is docked.
Intraoperative considerations
Induction and maintenance anesthesia
Any induction agent may be used if it is consistent with the
patient’s cardiovascular history and other co-morbid con-
ditions. Although choice of inhalation agent or non-depo-
larizing muscle relaxant is unimportant, complete muscle
relaxation is essential. This facilitates ease of mechanical
ventilation, introduction of surgical equipment, and creation
of PnP that enables optimal surgical working space and
visualization. An early indication of inadequate muscle
relaxation may be collapse of the PnP. Preoperative epidural
insertion for postoperative pain management is not recom-
mended, because this procedure is minimally invasive.
Positioning
A standard electrically operated or motorized table is used to
facilitate maneuvering of the patient into surgically favor-
able positions. Cushioned stirrups are used to place the pa-
tient in a modified lithotomy position. Arms and hands are
generously padded before they are tucked at the patient’s
sides. IV access and blood pressure cuff should be rechecked
and working in optimal fashion after the arms are tucked,
because of limited access after completion of patient posi-
tioning. RP surgical patients are prone to slipping off the
operating table during table position changes, particularly in
the 45 steep Trendelenburg position. The patient is,
therefore, well strapped to the operating room table with
chest binding in an ‘‘x’’ like pattern. Particular attention
should be paid to pressure areas, because of limited access
and the extended duration of the procedure. Both ulnar
neuropathy and lateral femoral cutaneous nerve injury may
occur if the arms or legs are improperly positioned and/or
inadequately padded. Preoperative evaluation should focus
on any pre-existing nerve injury with detailed documenta-
tion. Any suspected perioperative nerve injury should be
investigated immediately with electromyography and nerve
conduction studies to provide valuable clinical information.
Laparoscopy
At our institution all VIP procedures utilize carbon dioxide
(CO2) for PnP insufflation. Initially the abdomen is inflated
to achieve an IAP of 20 mm Hg to facilitate safe port
placement. When the laparoscopic ports have been placed,
IAP may be decreased to 12–15 mm Hg for the remainder
of the procedure.
Pneumoperitoneum is associated with multiple cardio-
vascular effects during laparoscopy and these changes may
be exacerbated in RP patients in the steep Trendelenburg
position. Previous studies have shown that an increase in
IAP results in an increase in systemic vascular resistance,
mean arterial pressure (MAP), and heart rate (HR), while
stroke volume decreases [10]. We have, however, found
that combination of the 45 steep Trendelenburg position
and insufflation pressures of 20 mm Hg result in a MAP
reduced by 17%, HR reduced by 21%, and cardiac output
reduced by 37% (Chow M et al., March 2004, Michigan
Society of Anesthesiologists). These cardiovascular chan-
ges may have adverse consequences in patients with lim-
ited cardiac reserve and invasive monitoring may be
necessary if prolonged operative times are expected. PnP
also results in impairment of respiratory mechanics [10].
Cephalad migration of the diaphragm and an increased IAP
cause peak and plateau pressures to rise by more than 50%
[10]. Pulmonary compliance is reduced and this continues
even after desufflation. We have found that chest binding,
steep 45 Trendelenburg position, and high insufflation
pressures reduces pulmonary compliance by 68%. These
pulmonary changes can have significant adverse conse-
quences for patients with abnormal pulmonary mechanics.
Absorption of carbon dioxide during prolonged PnP may
also lead to hybercarbia, which may be treated with in-
creases in ventilation rate. Although no patients required
conversion from VIP to open prostatectomy for high peak
airway pressures, 0.1% of cases (2/1,500) have been con-
verted because of excessive intra-abdominal adhesions
which obscured proper visualization.
Preoperative and intraoperative intravenous fluids are
kept to a minimum (<2,000 mL), because excessive urine
output can obscure the operative field during bladder neck
transection and urethrovesical anastomosis. Fluid restric-
tion also minimizes facial edema that can result from
prolonged use of the steep Trendelenburg position. Pha-
ryngeal and laryngeal edema may also be associated with
prolonged steep Trendelenburg position and an endotra-
cheal tube cuff leak test may be warranted before extuba-
tion. Because patients are volume-depleted by the
conclusion of the procedure, it is important to restore
hydration as soon as possible. We have identified that when
the urethrovesical anastomosis is complete and the patient
is returned to the supine position, intravenous fluids can be
restored rapidly with a 1-L bolus of lactated Ringer’s and
then infusion at 150 mL h–1 for the next 12–24 h,
depending on the patient’s volume status. Intravenous
ketorolac 15–30 mg is administered to all patients with
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normal renal function approximately 30 min before rever-
sal of anesthesia for postoperative analgesia.
Postoperative considerations
We analyzed the results of the first 1,500 VIPs performed by
three different surgeons at our institution. Most patients
undergoing VIP are discharged home within 24 h of surgery
(92%). Mean hospital stay is 1.2 days [11]. To enhance
discharge readiness and to maintain functionality patients
are encouraged to ambulate within a few hours of surgery.
All of the benefits of minimally invasive surgery apply to
VIP. These include less postoperative pain, cosmetic inci-
sions, and shorter hospitalization. Intravenous ketorolac and
acetaminophen with codeine are usually sufficient for pain
control. Immediate postoperative surgical pain should be
distinguished from bladder spasms, which are managed
with an opium and belladonna rectal suppository. Patients
are started on a clear liquid diet immediately postopera-
tively and diet is advanced as bowel function returns. Urine
output is a useful surrogate for assessing hydration status
and fluid boluses (500 mL lactated Ringers) are given if
urine output decreases to <0.5 mg mL h–1. SCDs, subcu-
taneous heparin, and early ambulation all help to reduce the
incidence of deep-vein thrombosis (DVT) and subsequent
pulmonary embolism (PE).
Postoperative complications
Postoperative ileus, abdominal distention, or nausea were
the most common complications, with an incidence of
1.7%. Most patients can be managed conservatively, with
intravenous fluids and bowel rest, whereas some patients
may require gastric decompression with a nasogastric tube.
Approximately 0.6% (10/1,500) patients required addi-
tional surgical intervention during their hospital stay. Three
patients required treatment for bowel injury, three for port
site hernias, three for intrabdominal bleeding, and one for
anastomosis revision. There was a 1.0% (15/1,500) inci-
dence of postoperative anemia (hemoglobin <10 g dL–1) in
which patients required blood transfusion. Approximately
0.2% (3/1,500) patients were diagnosed with postoperative
pulmonary emboli and were treated with IV heparin with
no additional sequelae.
The most common anesthesia-related complication was
corneal abrasion, which was seen in 3% of cases, despite
the use of eye tape. We were concerned that the extensive
degree of the Trendelenburg position put the patient at risk
of coming into contact with monitoring cables and we now
use eye patches for all patients. With the use of eye patches
we have been able to reduce the incidence of corneal
abrasions to 1%. Symptoms from corneal abrasions were
transient and there were no adverse long-term sequelae.
One patient developed forearm swelling secondary to
intravenous infiltration. The procedure was aborted, be-
cause of concern about compartment syndrome, and was
completed the next day. One patient who had a very dif-
ficult intubation developed postoperative bronchial edema
and required continued intubation overnight without fur-
ther sequelae.
Robotic failure has occurred perioperatively in 0.2%
(4/1,500) of cases. In one case the da Vinci surgical system
failed intraoperatively and a substitute robot was used.
Three other cases were delayed intraoperatively secondary
to software failures, all of which were resolved in the
operative suite without complications. At no time did
robotic failure require the cancellation of a case or pre-
mature emergence from anesthesia.
Conclusion
Robotic prostatectomy is a safe and established procedure
at our institution. Anesthestic management of these patients
should take into consideration the medical co-morbidities
associated with this patient population and medically
optimize patients before surgery. Overall, patients tolerate
the procedure well with minimal clinically significant
cardiopulmonary effects. For patients with limited cardio-
pulmonary reserve, however, physicians must weigh these
benefits with the negative cardiovascular and pulmonary
changes associated with this type of procedure.
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